European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 139, Issue 2 , Pages 139-145 , August 2008

A prospective randomized trial of acute tocolysis in term labour with atosiban or ritodrine

  • Roel de Heus

      Affiliations

    • Department of Perinatology & Gynecology, University Medical Centre Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author at: Department of Perinatology & Gynecology, University Medical Centre Utrecht, KJ.02.507.0/P.O. Box 85090, 3508 AB Utrecht, The Netherlands. Tel.: +31 62 4732630; fax: +31 30 2505320.
  • ,
  • Eduard J.H. Mulder

      Affiliations

    • Department of Perinatology & Gynecology, University Medical Centre Utrecht, The Netherlands
  • ,
  • Jan B. Derks

      Affiliations

    • Department of Perinatology & Gynecology, University Medical Centre Utrecht, The Netherlands
  • ,
  • Piet H.J. Kurver

      Affiliations

    • Holding P.H.J. Kurver B.V., De Meern, The Netherlands
  • ,
  • Leo van Wolfswinkel

      Affiliations

    • Department of Anesthesiology, University Medical Centre Utrecht, The Netherlands
  • ,
  • Gerard H.A. Visser

      Affiliations

    • Department of Perinatology & Gynecology, University Medical Centre Utrecht, The Netherlands

Received 10 July 2007 ,Revised 4 December 2007 ,Accepted 3 January 2008.

References 

  1. Chandraharan E, Arulkumaran S. Acute tocolysis. Curr Opin Obstet Gynecol. 2005;17:151–156
  2. Kulier R, Hofmeyr GJ. Tocolytics for suspected intrapartum fetal distress. Cochrane Database Syst Rev 2000CD000035.
  3. Kurup A, Arulkumaran S, Tay D, Ingemarsson I, Ratnam SS. Can terbutaline be used as a nebuliser instead of intravenous injection for inhibition of uterine activity?. Gynecol Obstet Invest. 1991;32:84–87
  4. Shekarloo A, Mendez-Bauer C, Cook V, Freese U. Terbutaline (intravenous bolus) for the treatment of acute intrapartum fetal distress. Am J Obstet Gynecol. 1989;160:615–618
  5. Gerris J, Thiery M, Bogaert M, De Schaepdryver A. Randomized trial of two beta-mimetic drugs (ritodrine and fenoterol) in acute intra-partum tocolysis. Eur J Clin Pharmacol. 1980;18:443–448
  6. Sheybany S, Murphy JF, Evans D, Newcombe RG, Pearson JF. Ritodrine in the management of fetal distress. Br J Obstet Gynaecol. 1982;89:723–726
  7. Magann EF, Cleveland RS, Dockery JR, Chauhan SP, Martin JN, Morrison JC. Acute tocolysis for fetal distress: terbutaline versus magnesium sulphate. Aust N Z J Obstet Gynaecol. 1993;33:362–364
  8. Buhimschi CS, Buhimschi IA, Malinow AM, Weiner CP. Effects of sublingual nitroglycerin on human uterine contractility during the active phase of labour. Am J Obstet Gynecol. 2002;187:235–238
  9. Moutquin JM, Sherman D, Cohen H, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labour: a multicenter effectiveness and safety study. Am J Obstet Gynecol. 2000;182:1191–1199
  10. The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. Br J Obstet Gynaecol. 2001;108:133–142
  11. Afschar P, Scholl W, Bader A, Bauer M, Winter R. A prospective randomized trial of atosiban versus hexoprenaline for acute tocolysis and intrauterine resuscitation. Br J Obstet Gynaecol. 2004;111:316–318
  12. Lurie S, Sadan O, Ben Aroya Z, Glezerman M. Atosiban treatment for uterine hyperactivity during active labour: a pilot study. J Perinat Med. 2004;32:137–139
  13. Barden TP, Peter JB, Merkatz IR. Ritodrine hydrochloride: a betamimetic agent for use in preterm labour. I. Pharmacology, clinical history, administration, side effects, and safety. Obstet Gynecol. 1980;56:1–6
  14. Lees CC, Lojacono A, Thompson C, et al. GTN Preterm Labour Investigation Group Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomized study. Obstet Gynecol. 1999;94:403–408
  15. Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004CD004352.
  16. van Lierde M, Thomas K. Ritodrine concentrations in maternal and fetal serum and amniotic fluid. J Perinat Med. 1982;10:119–124
  17. Mendez-Bauer C, Shekarloo A, Cook V, Freese U. Treatment of acute intrapartum fetal distress by beta 2-sympathomimetics. Am J Obstet Gynecol. 1987;156:638–642
  18. Cabero L, Vaz-Romero M, Cerqueira MJ, Bellart J, Duran-Sanchez P, Esteban-Altirriba J. Conservative treatment of intrapartum fetal acidosis with a betamimetic agent. Eur J Obstet Gynecol Reprod Biol. 1988;28:185–190
  19. Romero R, Sibai BM, Sanchez-Ramos L, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labour: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol. 2000;182:1173–1183
  20. Valenzuela GJ, Craig J, Bernhardt MD, Holland ML. Placental passage of the oxytocin antagonist atosiban. Am J Obstet Gynecol. 1995;172:1304–1306
  21. Fuchs AR, Fuchs F. Endocrinology of human parturition: a review. Br J Obstet Gynaecol. 1984;91:948–967
  22. Blanks AM, Thornton S. The role of oxytocin in parturition. Br J Obstet Gynaecol. 2003;110(Suppl 20):46–51
  23. Akerlund M, Stromberg P, Hauksson A, et al. Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol. 1987;94:1040–1044
  24. Reinheimer TM, Bee WH, Resendez JC, Meyer JK, Haluska GJ, Chellman GJ. Barusiban a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labour. J Clin Endocrinol Metab. 2005;90:2275–2281
  25. Ingemarsson I, Arulkumaran S, Ratnam SS. Single injection of terbutaline in term labour. II. Effect on uterine activity. Am J Obstet Gynecol. 1985;153:865–869

PII: S0301-2115(08)00008-0

doi: 10.1016/j.ejogrb.2008.01.001

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 139, Issue 2 , Pages 139-145 , August 2008